These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093 [TBL] [Abstract][Full Text] [Related]
4. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
5. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells. Dehm SM; Regan KM; Schmidt LJ; Tindall DJ Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941 [TBL] [Abstract][Full Text] [Related]
11. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865 [TBL] [Abstract][Full Text] [Related]
12. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943 [TBL] [Abstract][Full Text] [Related]
13. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Shin S; Janknecht R Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712 [TBL] [Abstract][Full Text] [Related]
14. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996 [TBL] [Abstract][Full Text] [Related]
16. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Schoenmakers E; Alen P; Verrijdt G; Peeters B; Verhoeven G; Rombauts W; Claessens F Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):515-21. PubMed ID: 10417312 [TBL] [Abstract][Full Text] [Related]
18. The androgen receptor: unlocking the secrets of its unique transactivation domain. Shen HC; Coetzee GA Vitam Horm; 2005; 71():301-19. PubMed ID: 16112272 [TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
20. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]